NBIXNasdaq United States
Market cap
$16.610 B
$163.41 +2.25%
Close of 7 Aug 2026
Revenue
$2.86B
#953 by revenue
Earnings
$478.6M
#631 by earnings
Shares outstanding
101,649,181
Latest filing cover page
P/E ratio
34.7
Cap ÷ net income
Where these numbers come from
Share counts and financials for Neurocrine Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.